RecruitingAtrial FibrillationObesityWeight Loss
DUTCH Weight Control in Atrial Fibrillation Study
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Quantify the effect of an innovative weight loss management on rhythm control.
Sponsor: Rijnstate Hospital
You may qualify if…
- ✓ Symptomatic, first detected (at maximum 6 months prior to enrollment) persistent AF -
- ✓ Age ≥ 18
- ✓ Obesity, as defined as:
- ✓ BMI ≥ 30 kg/m2, or
- ✓ BMI ≥27 kg/m2 with the presence of at least one weight related comorbidity (treated or untreated, e.g. hypertension, dyslipidaemia, obstructive sleep apnea, cardiovascular disease)
- ✓ Scheduled ECV
- ✓ Written informed consent
You may not qualify if…
- ✕ Permanent AF
- ✕ Secondary AF, i.e. due to thyrotoxicosis, infection (e.g. pneumonia) or post-(cardiothoracic) surgery
- ✕ Current or previous treatment with amiodaron
- ✕ HbA1c ≥ 48 mmol/L, \<3 months prior to randomization
- ✕ History of diabetes mellitus type 1 or 2
- ✕ Prior bariatric surgery
- ✕ Use of other anti-obesity medication, \<3 months prior to enrollment
- ✕ Contra-indication for, or prior use of a GLP1-receptor agonist
Source: ClinicalTrials.gov · NCT06184633 · last updated 2024-09-19